Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen. - Wikidata - wikimedia - TriplyDB

Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen.

Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen.

http://www.wikidata.org/entity/Q35779181

about

Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine Keep-ING balance: tumor suppression by epigenetic regulation Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity.Breast cancer associated with neurofibromatosis type 1: a case series and review of the literature ING5 suppresses breast cancer progression and is regulated by miR-24 The NF1 somatic mutational landscape in sporadic human cancers.Type II transmembrane serine protease gene variants associate with breast cancer.The NF1 gene revisited - from bench to bedside.Essential gene profiles in breast, pancreatic, and ovarian cancer cells.Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq data Optimized PCR conditions and increased shRNA fold representation improve reproducibility of pooled shRNA screens.Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis Cohesin is required for activation of MYC by estradiol.Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.Peptide Lv augments L-type voltage-gated calcium channels through vascular endothelial growth factor receptor 2 (VEGFR2) signaling.ING5 is phosphorylated by CDK2 and controls cell proliferation independently of p53 Enhanced expression of cohesin loading factor NIPBL confers poor prognosis and chemotherapy resistance in non-small cell lung cancer Progress in breast cancer research.Integrative Analysis of Response to Tamoxifen Treatment in ER-Positive Breast Cancer Using GWAS Information and Transcription Profiling The Ras-like protein R-Ras2/TC21 is important for proper mammary gland development.Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer In Vitro-Pooled shRNA Screening to Identify Determinants of Radiosensitivity.Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers.Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver.Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT An inhibitor of HIV-1 protease modulates constitutive eIF2α dephosphorylation to trigger a specific integrated stress response.Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations.Derailed estrogen signaling and breast cancer: an authentic couple.Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women Distinct genetic association at the PLCE1 locus with oesophageal squamous cell carcinoma in the South African population.Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition.Pan-cancer analyses of the nuclear receptor superfamily Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-α protein levels and activity.In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma.Understanding the language of Lys36 methylation at histone H3.Neurofibromatosis type I with breast cancer: not only for women!Contribution of the R-Ras2 GTP-binding protein to primary breast tumorigenesis and late-stage metastatic disease.Using titanium complexes to defeat cancer: the view from the shoulders of titans.

P2860

Q26800337-B89E9A3D-BCF7-4BD1-8ED3-F1E8CB3028C9 Q26859017-A86973B7-7A72-4D1A-AB85-595987F66C30 Q27852678-771B2373-9D30-41BA-828E-32D201E876CC Q28084508-8C8B496C-93A5-46AC-902A-C79391775527 Q33654764-344229F4-02AF-4891-85E9-697FFD8A4945 Q33823452-A2CFAC3F-373F-433D-AD12-C9009CB7C369 Q33910850-F39E942A-51A3-4775-9424-F5D887A8588D Q34227509-4C6F2A24-A565-4242-A554-50D61563BAAB Q34268870-A3EE7874-A793-450C-BDD0-7181135D5CA2 Q34356351-3DBFB85C-33D6-477D-90C6-C038CAB1E1F1 Q34369461-2879BFE3-910E-4066-AC05-F483050EEFF3 Q34416127-B39D79AE-C069-42C0-A043-46489648BC32 Q34474156-55B62686-A6F9-4BE7-AD23-6C861945E1A1 Q34664059-C8A52AFA-1F6D-40B7-9E68-998A23519205 Q35240917-F866A874-97C8-45F6-9FCC-0A28470550AC Q35599241-8EDFD265-A9AE-4C3E-A118-199E8420BE87 Q35627061-2ADB45F8-29BD-4F28-97F5-8B1077E02B5E Q35779144-0FA6FB5E-609A-4FF9-BA40-B3EA087C44F6 Q35799611-07C1CD39-5A2D-4FF9-BAF1-448E952E6FA9 Q36030517-4C43FB63-FF0F-4237-A39E-F2CD370FD15B Q36067934-4E414B71-2187-4466-8081-D7A0D3E4E7FB Q36118903-BCFD5C60-3131-481C-A31C-05709A129BE6 Q36245645-1657BFCE-823D-439C-A5B0-B897C34DF02C Q36268076-E562A59E-3D93-49B1-8B19-B7B22553E9BE Q36314597-1A981D75-D844-4CAF-AE86-DCFFFE1B098D Q36347158-DE75EC7F-6EB4-423B-AA6F-059273AE3B56 Q36483172-CCE6ADB4-12B1-4428-8560-30F041DF2371 Q36517144-3C1BA5C0-6DA4-44A3-8EFE-BEFC78A28672 Q36589361-BD523EBD-15F3-44D6-BDE7-330EF6CCC57A Q36645919-6227B8F2-A7AB-4C9A-BD72-079FB0988E01 Q36646995-C3BF22D6-2755-4CE5-9BFB-C0BCD1AEC331 Q36905632-5BE4B65A-207E-4E5A-8FB6-A70AADAD5477 Q36907762-16998253-D736-4ECE-AE92-35A9A3BC902F Q36912137-B34EFA99-9726-4F2F-80B1-2A0AA1A68D36 Q37101484-8BE75FD4-84F9-4D01-A446-49DBC96357D1 Q37323049-21E651E6-8433-444F-AFE1-FF3CA66F65D2 Q37672319-2D877D02-19D4-4D57-9089-FB70499B08F9 Q37681685-182CED84-0746-402B-9BAD-C8A81FA37A87 Q38995143-17519141-C327-4428-922F-A9BFC8B72694 Q38998355-A9E7DF7A-1C9B-4B88-8079-F39B1F5DB3AA

P2860

Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen.

http://www.wikidata.org/entity/Q35779181

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Genome-wide functional screen ...... ting sensitivity to tamoxifen.

@ast

Genome-wide functional screen ...... ting sensitivity to tamoxifen.

@en

type

label

Genome-wide functional screen ...... ting sensitivity to tamoxifen.

@ast

Genome-wide functional screen ...... ting sensitivity to tamoxifen.

@en

prefLabel

Genome-wide functional screen ...... ting sensitivity to tamoxifen.

@ast

Genome-wide functional screen ...... ting sensitivity to tamoxifen.

@en

P1433

Q35779181-11288199-9EA9-4309-9C6E-BE255FD5E776

P1476

Q35779181-48503D35-E970-4B37-8642-DBBF4525E6A0

P2093

Q35779181-0C908FC6-6D9F-4696-B26A-70A11C9B722C

Q35779181-151C3E42-DB88-4458-A520-D04C3EBE2B8F

Q35779181-1C9ABA91-6C28-4877-AB1C-008EA8177FD0

Q35779181-731C1296-FED1-4274-970C-0DB8DC8F1D1B

Q35779181-7F7F9CF3-13A5-49B8-96DD-515E76FB03B1

Q35779181-B198942B-4789-4AAD-AECD-99A89B1D297C

Q35779181-BA308D02-54DF-4019-AF7C-D83E82486095

Q35779181-EB959F60-4E3C-44A4-BBF1-BA7A458FA4E3

P2860

Q35779181-0603E8E6-6E35-44A7-A801-01CDF0F020AB

Q35779181-07744DB3-0B77-4683-AD38-AFF915315B3E

Q35779181-0BD3E8F8-22D4-4AED-A787-E51B63F83DF2

Q35779181-0D0AFE8C-6DF1-48D3-8ADB-958E46BC6FCE

Q35779181-0DFA5149-618C-4B14-86FF-A7674499ED7B

Q35779181-0E61A7D6-F154-46E9-9C9E-18F1DCE070BB

Q35779181-1BB0D65B-D34A-4B5E-85E3-964A18848760

Q35779181-1ED027EE-007C-4D75-B3BB-3C0638D72DA0

Q35779181-338C7ED6-6AE4-4D9E-BA5D-00B5EDAC461B

Q35779181-36013F0B-22E0-48B3-83A5-B1A68E2C342F

P304

Q35779181-BCD58074-7591-448D-A2FC-AEB61A39E6C7

P31

Q35779181-0E999029-AE4F-4899-B657-5ADDB24599E3

P356

Q35779181-45461980-68AE-4881-B773-180C4F54D471

P407

Q35779181-EDBD9377-F239-414F-877D-D5D99D02EE9C

P433

Q35779181-147EF90E-5DCC-4FD6-9AD0-EFCD59F0E78F

P478

Q35779181-18BEC26E-AB59-42BE-9DAA-38ACDD23ACF6

P50

Q35779181-401EA176-AA8D-4DDA-8F8F-91EF126159E3

Q35779181-6B102CD4-6A4D-4B32-AEA3-14372EC7E568

Q35779181-7DABE92B-F7EA-46F5-8027-EFD15136FB19

P577

Q35779181-E4A77D00-2848-4F6A-A413-A321DF42C0B6

P5875

Q35779181-BDE15B59-86EE-48F9-B5BE-3944D4E8380F

P698

Q35779181-5293609C-45AD-46B4-A64E-54989B2BA5BB

P932

Q35779181-58652CB1-6D9A-486D-94F8-1E9D7485E5F0

P356

PNAS.1018872108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Genome-wide functional screen ...... ting sensitivity to tamoxifen.

@en

P2093

Ana M Mendes-Pereira

http://www.w3.org/2001/XMLSchema#string

Costas Mitsopoulos

http://www.w3.org/2001/XMLSchema#string

David Sims

http://www.w3.org/2001/XMLSchema#string

Ioannis Assiotis

http://www.w3.org/2001/XMLSchema#string

Iwanka Kozarewa

http://www.w3.org/2001/XMLSchema#string

Jarle Hakas

http://www.w3.org/2001/XMLSchema#string

Kerry Fenwick

http://www.w3.org/2001/XMLSchema#string

Tim Dexter

http://www.w3.org/2001/XMLSchema#string

P2860

Transcriptional dysregulation in NIPBL and cohesin mutant human cells

Identification of the activating and conjugating enzymes of the NEDD8 conjugation pathway

Translating the Histone Code

Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer

STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene

A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance

A chromatin remodelling complex that loads cohesin onto human chromosomes

P304

2730-2735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1018872108

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Christopher J Lord

Marketa J Zvelebil

P577

2011-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51041569

http://www.w3.org/2001/XMLSchema#string

P698

21482774

http://www.w3.org/2001/XMLSchema#string

P932

3286962

http://www.w3.org/2001/XMLSchema#string